, December 7, 2022 (Newswire.com) - Financing provided exclusively by leading healthcare fund BVF Partners L.P. NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss ...

On April 2, 2026, MoonLake Immunotherapeutics (NASDAQ:MLTX) BVF Partners L.P. reported the direct sale of 3,750,000 shares of Common Stock for a total consideration of approximately $62.96 million, ...

Company previously aggressively rejected BVF, saying that it had better offers. In a turn of events, Avigen’s latest statement on Biotechnology Value Fund’s (BVF) $20.5 million buyout is neutral after ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity”) today announced a $20 million non-dilutive asset-backed financing ...

Biotechnology Value Fund, which holds a 30 percent stake in Avigen, will finally get that special shareholders meeting it's been pushing for later this month. The firm is urging fellow stockholders to ...

ZURICH, SWITZERLAND / ACCESSWIRE / December 7, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Financing provided exclusively by leading healthcare fund BVF Partners L.P. ZURICH, SWITZERLAND / ACCESSWIRE / December 7, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), ...